Skip to content
Buy This GLP
← Research
Evidence

Do GLP-1 Drugs Help Trigger Finger? What the Studies Measured

Three studies looked at different questions, including the chance of surgery after a steroid injection and recovery after release.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team5 min read
GLP-1 users against non-users, three cohortstrigger finger diagnosisfewer in usersStumpsurgery after a steroid shot10.6% vs 11.9% at 1 yrKhanrelease after diagnosismore in usersStumppain a year after release21.6% vs 16.9%Dameronrepeat release at 1 year11.4% vs 9.5%DameronEach study followed a different group of patients.

Trigger finger causes a finger or thumb to catch or lock when a tendon has trouble gliding through its sheath [4]. The tendon problem is distinct from diabetic peripheral neuropathy, which affects nerves and sensation. Usual care can include splinting or a corticosteroid injection. If symptoms persist, a surgeon may consider releasing the A1 pulley to make room for the tendon to glide [4].

What happened after a steroid injection?

One health records study matched 5,863 GLP-1 users with 5,863 nonusers. All had type 2 diabetes and received an initial corticosteroid injection for trigger finger. At one year, 10.6% of users and 11.9% of nonusers had a release (RR 0.89, 95% CI 0.81 to 0.99). At two years, 14.2% and 15.7% had surgery, respectively (RR 0.90, 95% CI 0.83 to 0.98). The difference at six months was statistically inconclusive [1].

A second study of people with type 2 diabetes found fewer trigger finger diagnoses among GLP-1 users overall and more release procedures among users who already had trigger finger[2]. That group was defined by a trigger finger diagnosis. The first study followed patients specifically after a steroid injection, so the two results answer different questions.

What happened after surgery?

In a third records study, each matched group included 4,283 patients who had a release. At one year, patients with GLP-1 exposure had more recorded pain (21.6% vs. 16.9%), scarring (2.3% vs. 1.5%), wound complications (2.3% vs. 1.4%), and repeat releases (11.4% vs. 9.5%) [3]. Infection rates were statistically similar.

Researchers counted GLP-1 exposure during the year before or after surgery. Because some patients could have had complications before starting the drug, this matters when interpreting the evidence on wound healing with GLP-1 drugs. The second study used preoperative exposure and found similar rates of selected complications within 90 days, including surgical site infection, joint stiffness and wound separation[2].

If you take a GLP-1 drug and plan to have surgery, discuss how to manage it before the procedure with your surgical team. These trigger finger studies did not test whether pausing medication changes surgical outcomes.

Frequently asked

Do GLP-1 drugs help trigger finger?
The available records studies do not establish that GLP-1 drugs treat trigger finger. One study found fewer release procedures after a steroid injection among users with type 2 diabetes, but other studies followed people at different points in their care.
Can these studies tell me whether to stop my GLP-1 before surgery?
No. The studies did not test medication pauses. One study counted use in the year before or after release. Discuss medication timing with your surgical team.

Sources

  1. [1] Khan AA, et al. (2026). GLP-1 Receptor Agonist Use and A1 Pulley Release After Corticosteroid Injection for Trigger Finger in Type 2 Diabetes Hand (New York, N.Y.). PMID 42678052
  2. [2] Stump K, et al. (2026). Relationship between glucagon-like peptide-1 receptor agonist use and incidence of trigger finger in patients with type 2 diabetes Hand surgery & rehabilitation. PMID 41619807
  3. [3] Dameron LS, et al. (2026). The Influence of Glucagon-like Peptide-1 Receptor Agonists on Outcomes Following Trigger Finger Release Journal of hand surgery global online. PMID 41657744
  4. [4] Gil JA, Hresko AM, Weiss AC (2020). Current Concepts in the Management of Trigger Finger in Adults Journal of the American Academy of Orthopaedic Surgeons. PMID 32732655

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence